We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HeartWare Touts Promising Pipeline During Third-Quarter Call
HeartWare Touts Promising Pipeline During Third-Quarter Call
HeartWare International plans to present data from the Endurance destination therapy trial of its ventricular assist device in early 2015 and could file a PMA sometime before that, CEO Doug Godshall said on a Thursday third-quarter earnings call.
